Skip to main content
OpenTrials
Completed

NCT Number: NCT03974048

Identification of the Epigenetic Response to Trauma

The objective of this study is to investigate potential early alterations in the DNA methylation profile after severe trauma and to investigate if the early marks persist.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Rigshospitalet

Copenhagen, 2100, Denmark

About this study

Background: Severe trauma is an extreme physical exposure, which may have significant consequences for the patient. In addition to anatomical injury and hemodynamic compromise, severe trauma causes an immense and rapid systemic immune reaction. At the genomic level, trauma has been found to significantly increase gene expression in circulating leukocytes, and preliminary data is also emerging that trauma may even cause epigenetic (DNA methylation) alterations.

Epigenetics, including DNA methylation, have been suggested as a mediator of genetic risk and to play a significant role in subsequent non-traumatic disease. Within the field of trauma DNA methylation has only been sparsely studied, but a few studies of traumatized animals have suggested that DNA methylation alterations may occur in relation to trauma. Even though DNA methylation is highly dynamic, some marks have been found to be stable over time, and thus may have long-term consequences.

An increasing understanding of the role of epigenetics in disease development and response may pave the way for new treatment targets and modalities for multiple diseases including trauma.

Research question: Does trauma induce immediate (<4 hours) and persistent (30 days post-trauma) changes in the epigenome of peripheral blood cells, and do epigenetic changes correlate with patient recovery?

Objectives: To identify potential early alterations in the DNA methylation profile after severe trauma AND to investigate if the early marks persist.

Study design: A prospective, observational, cohort study of trauma patients admitted to RH's trauma center. The trauma cohort will be compared to a cohort of patients admitted for elective orthopedic surgery in terms of DNA methylation profile in blood cells pre-trauma/surgery, immediately post-trauma/surgery, and 30-45 days post-trauma/surgery.

DNA methylation profiles will be assessed by array technique using Illumina's MethylationEPIC Bead-Chip.

Primary outcome: Immediate (<4 hours) post-trauma DNA methylation profile in blood cells.

Secondary outcomes: Pre-trauma/surgery DNA methylation profile, change in DNA methylation from pre-trauma/surgery to immediately and 30 days post-trauma/surgery, occurrence of organ dysfunction, sepsis, septic shock, 30-day mortality, ICU admission > 24 hours, ICU length of stay (LOS), hospital LOS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-65 years.
  • Trauma patients: Admitted to Rigshospitalet's trauma center generating a trauma team activation.
  • Surgical controls: Admitted for elective surgery (non-traumatic cause) at the orthopedics department AND
  • Only one surgical procedure planned from study day 0 to study day 45.
  • Expected procedure length of at least 60 minutes.

Exclusion criteria

  • Not able to obtain informed consent and not possible to obtain consent from a next-of-kin.
  • Trauma patients:
  • Secondary transfers.
  • Pre-hospital blood transfusion OR blood transfusion in the trauma center before the first blood sample is obtained.
  • First blood sample taken later than 4 hours after the trauma.
  • Patients in cardiac arrest before/after hospital admission.
  • Additional traumatic exposure requiring hospital admission between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • Surgery not related to the trauma between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • Surgical controls:
  • Surgical procedures due to cancer or fractures.
  • Traumatic exposure requiring hospital admission between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • Additional, unplanned surgery between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • First post-operative blood sample taken later than 4 hours after surgical end time.

Treatment and study plan

Blood samples for DNA methylation analysis

Diagnostic Test

DNA from blood samples will be isolated and analyzed for genome-wide DNA methylation patterns using the Infinium HumanMethylationEPIC BeadChip (Illumina, San Diego, CA, USA).

Primary outcomes

  1. Immediate DNA methylation profile

    Time frame: Day of trauma/surgery

    Immediate (< 4 hours) post-trauma DNA methylation profile in blood cells compared to the pre-surgery (baseline) and immediate post-surgery (< 4 hours) DNA methylation profile in blood cells.

Secondary outcomes

  1. Pre-trauma/-surgery DNA methylation profile

    Time frame: Pre-trauma/surgery

    Pre-trauma (if possible to obtain from an existing biobank) DNA methylation profile in blood cells compared to pre-surgery.

  2. Stability of DNA methylation profile

    Time frame: 30-45 days after trauma/surgery

    Persistence of the DNA methylation profile in blood cells 30-45 days after the trauma compared to surgical patients.

  3. Change in DNA methylation profile; pre-trauma/-surgery to post-trauma/-surgery

    Time frame: Day of trauma/surgery

    Change in DNA methylation profile in blood cells from pre-trauma (if possible to obtain) to immediately post-trauma compared to surgical patients.

  4. Change in DNA methylation profile; immediately post-trauma/-surgery to one month post-trauma/-surgery

    Time frame: 0 to 30-45 days after trauma/surgery

    Change in DNA methylation profile in blood cells from immediately post-trauma to 30-45 days post-trauma compared to surgical patients.

  5. DNA methylation changes in relation to injury severity

    Time frame: Day 0-45 after trauma/surgery

    Association of DNA methylation changes with injury severity. This will be done by comparing the DNA methylation profiles among patient with an injury severity score (ISS) < 15 and patients with an ISS > 15.

  6. Organ dysfunction

    Time frame: Day 30 after trauma/surgery

    Occurrence of organ dysfunction (increase of ≥ 2 in SOFA-score)

  7. Sepsis/septic shock

    Time frame: Day 30 after trauma/surgery

    Occurrence of sepsis or septic shock

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

Identification of the Epigenetic Response to Trauma - a Prospective, Observational Study

Acronym: TrauMeth

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jun 4, 2019
Registry last updated
Nov 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.